Biochip Market Key Players, Growth Impact and Demand

Product Type Insights
DNA chips accounted for the largest share of revenue owing to the presence of a considerable
number of applications. Cancer treatment/diagnostics has been observed to have major share
for the usage of biochips. Other segments contributing for the applications of biochips include
genotyping, agricultural biotechnology, genomic studies, single nucleotide polymorphism and
gene expression.
Biochip technology has the ability for miniaturizing chemical & biological assays and molecular
biology which provides a ground for in-depth R&D of molecular biology at a minute level.
Furthermore, the ability of miniaturization is expected to improve even more and enhance the
efficiency in terms of inputs and cost requirements.
Browse Full Research Report @
https://www.millioninsights.com/industry-reports/biochip-market-size
End-use Insights
Lab-on-a-chip, cell and tissue array, protein chips and DNA chips find applications in
biotechnology & pharmaceutical companies, research & academic institutes, hospitals &
diagnostics and point of care settings which involves end users. Protein biochips and LOACs have
found widespread use for single nucleotide polymorphism genotyping, gene expression, in vitro
diagnosis, expression profiling, drug discovery, high throughput screening and tissue arrays. The
commercialization of the products in the development pipelines of key market participants is
also key towards the potential to drive the growth for the market.
Sophisticated robotic tools are needed for scanning and handling samples which are in microscale.
Furthermore, for efficient data analysis efficient bioinformatics system is required.
Therefore, this will increase the need for specific techniques and system which is expected to
increase the demand for biochips used in sophisticated machines. This will consequently
increase the price of the biochips and widen the offered product range in the market.
Regional Insights
North-America accounted for the largest revenue share owing to the presence of government
policies motivating personalized care for the patients and availability of proteomics and genetic
profiling infrastructure across the country, especially in the U.S. There has also been a rise in the
usage of NGS (Next Generation Sequencing) for molecular treatment and clinical diagnosis
coupled with microfluidic techniques that add to the large market share.